MEDICA 2026 | 16–19 November 2026 | Hall 6, Stall F37 | Düsseldorf, Germany
Explore our CE & ISO 13485 certified disposable medical components engineered for reliable fluid management and infection control.
In modern clinical environments across Ireland—ranging from large acute hospitals under the Health Service Executive (HSE) to specialized nephrology clinics in Dublin, Cork, and Galway—maintaining venous catheter patency while preventing blood-borne pathogen contamination is a primary patient safety imperative. The Heparin Cap (Yellow Luer Lock Stopper) serves as a critical single-use interface in intravenous therapy, hemodialysis access, and central line management.
As a leading international manufacturer and OEM supplier of vascular access disposables, Lars Medicare provides engineering insights into the structural design, material selection, regulatory compliance, and localization trends shaping Heparin Cap procurement for Irish hospitals and medical device distributors.
A standard medical-grade Heparin Cap functions as a self-sealing injection port fitted to the female Luer lock connector of peripheral IV cannulas, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), and hemodialysis lines. Its core mechanical objective is twofold: to enable repeated needle insertion for heparinization or medication delivery without fluid leakage, and to maintain an airtight microbial barrier when unpunctured.
Lars Medicare Heparin Caps are designed with micro-dead-space internal geometry (<0.04 mL) and crafted from medical-grade polycarbonate combined with DEHP-free, latex-free synthetic polyisoprene rubber septums. This guarantees ultra-low displacement volume during insertion and eliminates latex allergy risks across Irish clinical facilities.
| Specification Parameter | Lars Medicare Technical Standard | Clinical Relevance for Irish Hospitals |
|---|---|---|
| Connector Compliance | ISO 80369-7 Standard 6% Male Luer Lock | Universal connection compatibility with all HSE-approved IV catheters, 3-way stopcocks, and extension sets. |
| Septum Material | Self-sealing Medical Polyisoprene Rubber (Latex-Free) | Prevents coring, allows up to 100+ clean punctures without residual leakage or mechanical breakdown. |
| Housing Construction | Rigid Polycarbonate / Polypropylene (DEHP-Free) | High transparency for visual verification; resistant to lipid cracking, alcohol degradation, and stress fractures. |
| Internal Dead Space | Optimized < 0.04 mL Micro-Volume | Minimizes blood stagnation, lowers risk of luminal thrombosis, and reduces wasted drug volume during flushing. |
| Sterilization Method | Validated Ethylene Oxide (EO) Gas (ISO 11135) | Achieves a Sterility Assurance Level (SAL) of 10⁻⁶ with strict residual limits compliant with EN ISO 10993-7. |
| Color Coding | Standardized International Yellow (Custom Colors Available) | Immediate visual identification by nursing staff in high-acuity wards, ICU, and emergency departments. |
The healthcare landscape in Ireland is undergoing rapid modernization driven by the national Sláintecare framework, which emphasizes shifting acute hospital care toward streamlined community treatment and high-efficiency regional clinical hubs. Heparin Caps play a essential role in several key medical workflows across the country:
In major dialysis centers such as Dublin's Beaumont Hospital and Cork University Hospital, Heparin Caps lock vascular access catheters between hemodialysis sessions, maintaining anti-coagulation integrity without risk of external bacterial ingress.
Outpatient oncology clinics utilize Heparin Caps on long-term indwelling ports and PICC lines. Their tight Luer-lock seal protects immunocompromised cancer patients against Catheter-Related Bloodstream Infections (CRBSIs).
Ireland's expanding community care programs enable patients requiring IV nutrition to manage their central lines at home. Simple, robust, leak-proof Heparin Caps are critical for preventing accidental line disconnects outside hospital walls.
Medical consumable procurement in Ireland is strictly governed by the Health Products Regulatory Authority (HPRA) under the overarching EU Medical Device Regulation (EU MDR 2017/745). Suppliers aiming to serve Irish hospital tenders or private medical distributors must adhere to key market developments:
Lars Medicare operates an integrated, end-to-end manufacturing complex in Sonepat, India, designed to fulfill the exacting standards demanded by European healthcare buyers. Unlike trading intermediaries, we control every critical phase of production under one quality management system certified to ISO 13485:2016 and CE marks.
Our fully equipped tool room designs and maintains precision injection molds, allowing custom gauge adjustments, low-dead-space geometries, and customized brand logos directly molded into component bodies.
All component feeding, automatic rubber insertion, ultrasonic bonding, and blister sealing occur inside monitored Class 8 cleanrooms to keep particulate counts and bioburden far below European limits.
Equipped with fully automated Ethylene Oxide (EO) sterilizers, we validate every sterilization cycle per ISO 11135, conducting chemical indicator verification, biological spore testing, and EO residue analysis before batch release.
Direct answers regarding regulatory documentation, lead times, OEM options, and distribution logistics for Irish hospital groups and medical distributors.
Every shipment of Heparin Caps supplied to Ireland is backed by a full European compliance dossier, including an ISO 13485:2016 Quality Management Certificate, CE Mark Certificate, EC Declaration of Conformity, Certificate of Free Sale (CFS), batch-specific Certificate of Analysis (CoA), EO Sterilization Validation Report, and ISO 10993 Biocompatibility Test Reports (cytotoxicity, sensitization, and systemic toxicity).
Yes. To comply with HSE standards and broader EU environmental health guidelines, our Heparin Caps are manufactured using medical-grade polycarbonate and synthetic polyisoprene rubber septums. They are completely free of DEHP, phthalates, and natural rubber latex, eliminating patient allergy concerns and toxic leaching risks during prolonged fluid contact.
Absoutely. We provide complete OEM and private-label manufacturing solutions for Irish medical brands and distributors. This includes custom blister foil printing, artwork design, multi-lingual Instructions for Use (IFU) compliant with EU regulations, customized outer carton packaging, and GS1-compliant UDI barcoding for seamless warehouse management.
For standard catalogue orders, repeat shipments dispatch within 3 to 4 weeks. First-time private-label OEM orders take 5 to 6 weeks to allow artwork proofing and sterilization validation. Sea freight consignments ship directly to Dublin Port or Rosslare, while urgent medical orders are routed via Dublin Airport (DDP/FOB/CIF terms available).
Our high-density synthetic polyisoprene rubber septum is engineered for high elasticity and puncture memory. Rigorous laboratory testing confirms that the cap maintains liquid tightness up to 3.0 bar hydrostatic pressure even after 100 consecutive punctures using standard 21G hypodermic needles, ensuring zero leakages during active clinical use.
Yes, we provide free sterile sample packs complete with technical datasheets and certificates for clinical evaluation, hospital trial sign-offs, and distributor lab testing across Ireland. Click the inquiry button to request your sample kit.
